Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation.

Rentz AM, Yu R, Müller-Lissner S, Leyendecker P.

J Med Econ. 2009;12(4):371-83. doi: 10.3111/13696990903430481.

PMID:
19912069
2.

Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial.

Löwenstein O, Leyendecker P, Hopp M, Schutter U, Rogers PD, Uhl R, Bond S, Kremers W, Nichols T, Krain B, Reimer K.

Expert Opin Pharmacother. 2009 Mar;10(4):531-43. doi: 10.1517/14656560902796798 .

PMID:
19243306
3.

A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.

Meissner W, Leyendecker P, Mueller-Lissner S, Nadstawek J, Hopp M, Ruckes C, Wirz S, Fleischer W, Reimer K.

Eur J Pain. 2009 Jan;13(1):56-64. doi: 10.1016/j.ejpain.2008.06.012. Epub 2008 Aug 31.

PMID:
18762438
4.

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.

Simpson K, Leyendecker P, Hopp M, Müller-Lissner S, Löwenstein O, De Andrés J, Troy Ferrarons J, Bosse B, Krain B, Nichols T, Kremers W, Reimer K.

Curr Med Res Opin. 2008 Dec;24(12):3503-12. doi: 10.1185/03007990802584454 .

PMID:
19032132
5.

Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.

Vondrackova D, Leyendecker P, Meissner W, Hopp M, Szombati I, Hermanns K, Ruckes C, Weber S, Grothe B, Fleischer W, Reimer K.

J Pain. 2008 Dec;9(12):1144-54. doi: 10.1016/j.jpain.2008.06.014. Epub 2008 Aug 16.

PMID:
18708300
6.

Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.

Hermanns K, Junker U, Nolte T.

Expert Opin Pharmacother. 2012 Feb;13(3):299-311. doi: 10.1517/14656566.2012.648615. Epub 2012 Jan 6.

PMID:
22224497
7.

Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain.

Sandner-Kiesling A, Leyendecker P, Hopp M, Tarau L, Lejcko J, Meissner W, Sevcik P, Hakl M, Hrib R, Uhl R, Dürr H, Reimer K.

Int J Clin Pract. 2010 May;64(6):763-74. doi: 10.1111/j.1742-1241.2010.02360.x. Epub 2010 Mar 29.

8.

Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.

Lazzari M, Greco MT, Marcassa C, Finocchi S, Caldarulo C, Corli O.

Drug Des Devel Ther. 2015 Nov 2;9:5863-72. doi: 10.2147/DDDT.S92998. eCollection 2015.

9.

A comparison of oxycodone prolonged-release vs. oxycodone + naloxone prolonged-release after laparoscopic hysterectomy.

Comelon M, Wisloeff-Aase K, Raeder J, Draegni T, Undersrud H, Qvigstad E, Bjerkelund CE, Lenz H.

Acta Anaesthesiol Scand. 2013 Apr;57(4):509-17. doi: 10.1111/aas.12051. Epub 2013 Jan 10.

PMID:
23301686
10.

Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation.

Burness CB, Keating GM.

Drugs. 2014 Mar;74(3):353-75. doi: 10.1007/s40265-014-0177-9. Review. Erratum in: Drugs. 2014 Mar;74(3):401-2.

PMID:
24452879
11.
12.

Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain.

Nadstawek J, Leyendecker P, Hopp M, Ruckes C, Wirz S, Fleischer W, Reimer K.

Int J Clin Pract. 2008 Aug;62(8):1159-67. doi: 10.1111/j.1742-1241.2008.01820.x.

13.
14.

Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.

Koopmans G, Simpson K, De Andrés J, Lux EA, Wagemans M, Van Megen Y.

Curr Med Res Opin. 2014 Nov;30(11):2389-96. doi: 10.1185/03007995.2014.971355. Epub 2014 Oct 13.

PMID:
25265132
15.

[Quality of life suffers much in constipation. Plea for an intelligent pain therapy].

[No authors listed]

MMW Fortschr Med. 2006 Aug 31;148(35-36):55. German. No abstract available.

PMID:
16995370
16.

Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer.

Clemens KE, Quednau I, Klaschik E.

Int J Clin Pract. 2011 Apr;65(4):472-8. doi: 10.1111/j.1742-1241.2011.02634.x.

PMID:
21401835
17.

The attractiveness of opposites: agonists and antagonists.

O'Brien T.

J Pain Palliat Care Pharmacother. 2015 Mar;29(1):67-9. doi: 10.3109/15360288.2014.1003680. Epub 2015 Feb 2.

PMID:
25643224
18.

Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain.

Slappendel R, Simpson K, Dubois D, Keininger DL.

Eur J Pain. 2006 Apr;10(3):209-17.

PMID:
15914049
19.

Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone.

Morlion B, Clemens KE, Dunlop W.

Clin Drug Investig. 2015 Jan;35(1):1-11. doi: 10.1007/s40261-014-0254-6. Review.

20.

Supplemental Content

Support Center